Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 28;2014(8):CD010761.
doi: 10.1002/14651858.CD010761.pub2.

Interventions for treating acute bleeding episodes in people with acquired hemophilia A

Yan Zeng  1 , Ruiqing Zhou, Xin Duan, Dan Long, Songtao Yang
Affiliations

Interventions for treating acute bleeding episodes in people with acquired hemophilia A

Yan Zeng et al. Cochrane Database Syst Rev. .

Abstract

Background: Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies to coagulation factor VIII (FVIII). In most cases, bleeding episodes are spontaneous and severe at presentation. The optimal hemostatic therapy is controversial.

Objectives: To determine the efficacy of hemostatic therapies for acute bleeds in people with acquired hemophilia A; and to compare different forms of therapy for these bleeds.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2014, Issue 4) and MEDLINE (Ovid) (1948 to 30 April 2014). We searched the conference proceedings of the: American Society of Hematology; European Hematology Association; International Society on Thrombosis and Haemostasis (ISTH); and the European Association for Haemophilia and Allied Disorders (EAHAD) (from 2000 to 30 April 2014). In addition to this we searched clinical trials registers.

Selection criteria: All randomised controlled trials and quasi-randomised trials of hemostatic therapies for people with acquired hemophilia A, with no restrictions on gender, age or ethnicity.

Data collection and analysis: No trials matching the selection criteria were eligible for inclusion.

Main results: No trials matching the selection criteria were eligible for inclusion.

Authors' conclusions: No randomised clinical trials of hemostatic therapies for acquired hemophilia A were found. Thus, we are not able to draw any conclusions or make any recommendations on the optimal hemostatic therapies for acquired hemophilia A based on the highest quality of evidence. GIven that carrying out randomized controlled trials in this field is a complex task, the authors suggest that, while planning randomised controlled trials in which patients can be enrolled, clinicians treating the disease continue to base their choices on alternative, lower quality sources of evidence, which hopefully, in the future, will also be appraised and incorporated in a Cochrane Review.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
Study flow diagram.
See this image and copyright information in PMC

Update of

  • doi: 10.1002/14651858.CD010761

Similar articles

See all similar articles

Cited by

References

References to studies excluded from this review

Baudo 2004b  {published data only}
    1. Baudo F, Cataldo F, Gaidano G. Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia. Haematologica 2004;89(6):759–61. - PubMed
Baudo 2010 {published data only}
    1. Baudo F, Caimi T, Cataldo FDE. Diagnosis and treatment of acquired haemophilia. Haemophilia 2010;16(102):102-6. - PubMed
Bossi 1998 {published data only}
    1. Bossi P, Cabane J, Ninet J, Dhote R, Hanslik T, Chosidow O, et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. American Journal of Medicine 1998 Nov;105(5):400-8. - PubMed
Buczma 2007 {published data only}
    1. Buczma A, Windyga J. Acquired haemophilia. Polskie Archiwum Medycyny Wewnętrznej 2007;117(5-6):241-5. - PubMed
Burnet 2001 {published data only}
    1. Burnet SP, Duncan EM, Lloyd JV, Han P. Acquired haemophilia in South Australia: a case series. Internal Medicine Journal 2001;31(9):556-9. - PubMed
Chai‐Adisaksopha 2014 {published data only}
    1. Chai-Adisaksopha C, Rattarittamrong E, Norasetthada L, Tantiworawit A, Nawarawong W. Younger age at presentation of acquired haemophilia A in Asian countries: a single-centre study and systematic review. Haemophilia 2014;20(3):e205-10. - PubMed
Chistolini 1987 {published data only}
    1. Chistolini A, Ghirardini A, Tirindelli MC, et al. Inhibitor to factor VIII in a non-haemophilic patient: evaluation of the response to DDAVP and the in vitro kinetics of factor VIII. A case report. Nouvelle Revue Francaise d'Hematologie 1987;29(4):221-4. - PubMed
Collins 2004 {published data only}
    1. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. British Journal of Haematology 2004;124(1):86-90. - PubMed
Collins 2007a {published data only}
    1. Collins PW, Hirsch S, Baglin TP, Dolan G, Hanley J, Makris M, et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood 2007;109(5):1870-7. - PubMed
Collins 2010 {published data only}
    1. Collins P, Baudo F, Huth-Kuhne A, Ingerslev J, Kessler CM, Castellano ME, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Research Notes 2010;3:161. - PMC - PubMed
Coppola 2009 {published data only}
    1. Coppola A, Capua MD, Di Minno MND, Cerbone AM. Acquired Hemophilia: An Overview on Diagnosis and Treatment. Open Atherosclerosis & Thrombosis Journal 2009;2(2):29-32.
de la Fuente 1985 {published data only}
    1. la Fuente B, Panek S, Hoyer LW. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor. British Journal of Haematology 1985;59(1):127-31. - PubMed
Delgado 2002 {published data only}
    1. Delgado J, Villar A, Jimenez-Yuste V, Gago J, Quintana M, Hernandez-Navarro F. Acquired hemophilia: a single-center survey with emphasis on immunotherapy and treatment-related side-effects. European Journal of Haematology 2002;69(3):158-64. - PubMed
Delgado 2003 {published data only}
    1. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. British Journal of Haematology 2003;121(1):21-35. - PubMed
Di Bona 1997 {published data only}
    1. Di Bona E, Schiavoni M, Castaman G, et al. Acquired hemophilia: experience of two Italian centres with 17 new cases. Haemophilia 1997;3:183-8. - PubMed
Di Capua 2014 {published data only}
    1. Di Capua M, Coppola A, Nardo A, Cimino E, Di Minno MN, Tufano A, et al. Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases. Blood Transfusion 2014;19:1-5. - PMC - PubMed
EACH2 2012 {published data only}
    1. Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012;120(1):39-46. - PubMed
    1. Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012;120(1):47-55. - PMC - PubMed
    1. Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Journal of Thrombosis and Haemostasis 2012;10(4):622-31. - PubMed
    1. Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, Lévesque H, Marco P, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG: an international journal of obstetrics and gynaecology 2012;119(12):1529–37. - PubMed
Franchini 2008 {published data only}
    1. Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood 2008;112(2):250-5. - PubMed
Franchini 2011 {published data only}
    1. Franchini M, Lippi G. The use of desmopressin in acquired haemophilia A: a systematic review. Blood Transfusion 2011;9(4):377-82. - PMC - PubMed
Franchini 2013 {published data only}
    1. Franchini M, Mannucci PM. Acquired haemophilia A: a 2013 update. Thrombosis and Haemostasis 2013;110(6):1114-20. - PubMed
Goudemand 2004 {published data only}
    1. Goudemand J. Treatment of bleeding episodes occurring in patients with acquired haemophilia with FEIBA: the French experience. Haemophilia 2004;10 Suppl 3:14.
Hasson 1986 {published data only}
    1. Hasson DM, Poole AE, la Fuente B, Hoyer LW. Dental management of patients with spontaneous acquired factor VIII inhibitors. Journal of the American Dental Association 1986;113(4):633-6. - PubMed
Hay 1997 {published data only}
    1. Hay CRM, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thrombosis and Haemostasis 1997;78(6):3-7. - PubMed
Hay 2006 {published data only}
    1. Hay CR, Brown S, Collins PW, KeelingDM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. British Journal of Haematology 2006;133(6):591-605. - PubMed
Howland 2002 {published data only}
    1. Howland EJ, Palmer J, Lumley M, Keay SD. Acquired factor VIII inhibitors as a cause of primary post-partum haemorrhage. European Jouurnal of Obstetrics, Gynecology, and Reproductive Biology 2002;103(1):97-8. - PubMed
Huth‐Kühne 2009 {published data only}
    1. Huth-Kühne A, Baudo F, Collins P, Ingerslev J, Kessler CM, Lévesque H, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica 2009;94(4):566-75. - PMC - PubMed
Ilkhchoui 2013 {published data only}
    1. Ilkhchoui Y, Koshkin E, Windsor JJ, Petersen TR, Charles M, Pack JD. Perioperative management of acquired hemophilia a: a case report and review of literature. Anestheisiology and Pain Medicine 2013;4(1):e11906. - PMC - PubMed
Kyaw 2013 {published data only}
    1. Kyaw TZ, Jayaranee S, Bee PC, Chin EF. Acquired Factor VIII Inhibitors: Three Cases. Turkish Journal of Hematology 2013;30(1):76-80. - PMC - PubMed
Ma 2011 {published data only}
    1. Ma A, Kessler CM, Gut RZ, Cooper DL. Treatment of acquired haemophilia with recombinant factor VIIa (rFVIIa): an updated analysis from the hemophilia and thrombosis research society (HTRS) registry. Journal of Thrombosis and Haemostasis 2011;9(Suppl 2):476.
Morrison 1993 {published data only}
    1. Morrison AE, Ludlam CA, Kessler C. Use of Porcine Factor VIII in the Treatment of Patients With Acquired Hemophilia. Blood 1993;81(6):1513-20. - PubMed
Mudad 1993 {published data only}
    1. Mudad R, Kane WH. DDAVP in acquired hemophilia A: case report and review of the literature. American Journal of Hematology 1993;43(4):295-9. - PubMed
Muhm 1990 {published data only}
    1. Muhm M, Grois N, Kier P, Stümpflen A, et al. 1-Deamino-8-D-arginine vasopressin in the treatment of non-haemophilic patients with acquired factor VIII inhibitor. Haemostasis 1990;20(1):15-20. - PubMed
Naarose‐Abidi 1988 {published data only}
    1. Naarose-Abidi SM, Bond LR, Chitolie A, Bevan DH. Desmopressin therapy in patients with acquired factor VIII inhibitors. Lancet 1988;1(8581):366. - PubMed
Nilsson 1991 {published data only}
    1. Nilsson IM, Lethagen S. Current status of DDAVP formulations and their use. Excerpta Medica 1991;943:443-53.
Sallah 2004 {published data only}
    1. Sallah S. Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia 2004;10(2):169-73. - PubMed
Sborov 2013 {published data only}
    1. Sborov DW, Rodgers GM. How I manage patients with acquired haemophilia A. British Journal of Haematology 2013;161(2):157-65. - PubMed
Sumner 2007 {published data only}
    1. Sumner MJ, Geldziler BD, Pedersen M, Seremetis S. Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia 2007;13(5):451-61. - PubMed
Vincente 1985 {published data only}
    1. Vincente V, Corrales J, Miralles J, Alberca I. DDAVP in a non-haemophiliac patient with an acquired factor VIII inhibitor. British Journal of Haematology 1985;60:585-6. - PubMed
Vivaldi 1993 {published data only}
    1. Vivaldi P, Savino M, Mazzon C, Rubertelli M. A hemorrhagic syndrome of the elderly patient caused by anti-factor VIII antibodies. Haematologica 1993;78:245-8. - PubMed
Yang 2013 {published data only}
    1. Yang Y, Xue F, Shi H, Wang H, Zhang L, Ji L, Yang R. Acquired Hemophilia A: Retrospective Analysis of 49 Cases From a Single Chinese Hemophilia Center. Clinical and Applied Thrombosis/Hemostasis 2013 [Epub ahead of print]. - PubMed
Yee 2000 {published data only}
    1. Yee TT, Taher A, Pasi KJ, Lee CA. A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clinical and Laboratory Haematology 2000;22(5):275-8. - PubMed
Zanon 2013 {published data only}
    1. Zanon E, Milan M, Brandolin B, Barbar S, Spiezia L, Saggiorato G, et al. High dose of human plasma-derived FVIII-VWF as first-line therapy in patients affected by acquired haemophilia A and concomitant cardiovascular disease: four case reports and a literature review. Haemophilia 2013;19(1):e50-3. - PubMed

Additional references

Abshire 2004
    1. Abshire T, Kenet G. Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIIIor IX inhibitors. Journal of Thrombosis and Haemostasis 2004;2(6):899-909. - PubMed
Ananyeva 2009
    1. Ananyeva NM, Lee TK, Jain N, Shima M, Saenko EL. Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents. Seminars in Thrombosis and Hemostasis 2009;35(8):735-51. - PubMed
Baudo 2003
    1. Baudo F, Mostarda G, Cataldo F. Acquired factor VIII and factor IX inhibitors: survey of the Italian haemophila centers (AICE). Haematologica 2003;88 Suppl 12:93-9.
Baudo 2004a
    1. Baudo F, Cataldo F. Acquired hemophilia: acritical bleeding syndrome. Haematologica 2004;89(1):96-100. - PubMed
Baudo 2007
    1. Baudo F, Cataldo F. Acquired haemophilia in the elderly. In: Balducci L, Ershler W, Gaetano G, editors(s). Blood Disorders in the Elderly. Cambridge: Cambridge University Press, 2007:389–407.
Baudo 2012
    1. Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, et al. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood 2012;120(1):39-46. - PubMed
Boggio 2001
    1. Boggio LN, Green D. Acquired hemophilia. Reviews in Clinical and Experimental Hematology 2001;5(4):389-404. - PubMed
Collins 2007b
    1. Collins PW. Treatment of acquired hemophilia A. Journal of Thrombosis and Haemostasis 2007;5(5):893-900. - PubMed
Collins 2012
    1. Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood 2012;120(1):47-55. - PMC - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
de la Fuente 1995
    1. la Fuente B, Panek S, Hoyer LW. The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor. British Journal of Haematology 1985;59(1):127-31. - PubMed
Dreyer 2009
    1. Dreyer NA, Garner S. Registries for robust evidence. JAMA 2009;302(7):790-1. - PubMed
Elbourne 2002
    1. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analysis involving cross-over trials:methodological issues. International Journal of Epidemiology 2002;31(1):140-9. - PubMed
Franchini 2008a
    1. Franchini M, Tragher G, Manzato F, Lippi G. Acquired factor VIII inhibitors in oncohematology: a systematic review. Critical Reviews in Oncology/Hematology 2008;66(3):194-9. - PubMed
Green 1981
    1. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thrombosis and Haemostasis 1981;45(3):200-3. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
    1. Higgins JPT, Altman DG, Sterne JAC, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011c
    1. Higgins JPT, Deeks JJ, Altman DG, on behalf of the Cochrane Statistical Methods Group. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Knoebl 2012
    1. Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, et al. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Journal of Thrombosis and Haemostasis 2012;10(4):622-31. - PubMed
Lefebvre 2011
    1. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S, editors(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Lethagen 1987
    1. Lethagen S, Harris AS, Sjorin E, Nilsson IM. Intranasal and intravenous administration of desmopressin: effect on FVIII/vWF, pharmacokinetics and reproducibility. Thrombosis and Haemostasis 1987;58(4):1033-6. - PubMed
Lilford 1995
    1. Lilford RJ, Thornton JG, Braunholtz D. Clinical trials and rare diseases: a way out of a conundrum. BMJ 1995;311(7020):1621-5. - PMC - PubMed
Lipscomb 2009
    1. Lipscomb J, Yabroff R, Brown ML. Health care costing: data, methods, current applications. Medical Care 2009;47(7 Suppl 1):S1-6. - PubMed
Meiklejohn 2001
    1. Meiklejohn DJ, Watson HG. Acquired haemophilia in association with organ-specific autoimmune disease. Haemophilia 2001;7(5):523-5. - PubMed
Naarose‐Abidi 1988
    1. Naarose-Abidi SM, Bond LR, Chitolie A, Bevan DH. Desmopressin therapy in patients with acquired factor VIII inhibitors. Lancet 1988;1(8581):366. - PubMed
National Academies Press 2001
    1. Committee on Strategies for Small-Number-Participant Clinical Research Trials, Board on Health Sciences Policy. Small Clinical Trials: Issues and Challenges (The National Academies Press). http://www.nap.edu/catalog.php?record_id=10078 (accessed 30 January 2014).
Parmar 1998
    1. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815-34. - PubMed
RevMan 2013 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Sterne 2011
    1. Sterne JAC, Egger M, Moher D, on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Temple 1982
    1. Temple RJ. Government viewpoint of clinical trials. Drug Information Journal 1982;16:10-7.
Tengborn 2012
    1. Tengborn L, Baudo F, Huth-Kuhne A, Knoebl P, Levesque H, Marco P, et al. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG: An International Journal of Obstetrics and Gynaecology 2012;119(12):1529-37. - PubMed
Tierney 2007
    1. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007;8:16. - PMC - PubMed
Turecek 2004
    1. Turecek PL, Váradi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004;10 Suppl 2:3-9. - PubMed
Verbruggen 1995
    1. Verbruggen B, Novakova I, Wessels H, Boezeman J, den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thrombosis and Haemostasis 1995;73(2):247-51. - PubMed

Publication types

LinkOut - more resources